These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18688653)

  • 21. Quality of life assessment in hematopoietic stem cell transplantation performed on thalassemia major patients.
    Uygun V; Tayfun F; Akcan M; Karasu GT; Kupesiz A; Hazar V; Yeşilipek A
    Pediatr Hematol Oncol; 2012 Aug; 29(5):461-71. PubMed ID: 22712884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal tubular dysfunction in alpha-thalassemia.
    Sumboonnanonda A; Malasit P; Tanphaichitr VS; Ong-ajyooth S; Petrarat S; Vongjirad A
    Pediatr Nephrol; 2003 Mar; 18(3):257-60. PubMed ID: 12644919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiota trajectory in β-thalassemia major children who underwent allogeneic hematopoietic stem cell transplantation.
    Luo H; Liu T; Qu Y; Kuang C; Xiao M; Sun J; Chen H; Wu J; Liu X; Jiang H
    Transpl Infect Dis; 2023 Oct; 25(5):e14111. PubMed ID: 37615262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Documentation of renal glomerular and tubular impairment and glomerular hyperfiltration in multitransfused patients with beta thalassemia.
    Deveci B; Kurtoglu A; Kurtoglu E; Salim O; Toptas T
    Ann Hematol; 2016 Feb; 95(3):375-81. PubMed ID: 26596972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal tubular function in beta-thalassemia.
    Sumboonnanonda A; Malasit P; Tanphaichitr VS; Ong-ajyooth S; Sunthornchart S; Pattanakitsakul S; Petrarat S; Assateerawatt A; Vongjirad A
    Pediatr Nephrol; 1998 May; 12(4):280-3. PubMed ID: 9655357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing outcome and incidence of late complications in children who underwent allogeneic hematopoietic stem cell transplantation for hemoglobinopathy.
    Khalil A; Zaidman I; Elhasid R; Peretz-Nahum M; Futerman B; Ben-Arush M
    Pediatr Hematol Oncol; 2012 Nov; 29(8):694-703. PubMed ID: 23020512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of β-globin mutations on outcome of matched related donor hematopoietic stem cell transplantation for patients with β-thalassemia major.
    Hamidieh AA; Saber T; Fayyazi S; Jalali A; Behfar M; Hamdi A; Ghavamzadeh A
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1772-6. PubMed ID: 25017762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell Transplantation.
    Coquerelle S; Ghardallou M; Rais S; Taupin P; Touzot F; Boquet L; Blanche S; Benaouadi S; Brice T; Tuchmann-Durand C; Ribeil JA; Magrin E; Lissillour E; Rochaix L; Cavazzana M; Durand-Zaleski I
    Hum Gene Ther; 2019 Jun; 30(6):753-761. PubMed ID: 30700149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematopoietic stem cell transplantation for children with β-thalassemia major: multicenter experience in China.
    Li XY; Sun X; Chen J; Qin MQ; Luan Z; Zhu YP; Fang JP
    World J Pediatr; 2018 Feb; 14(1):92-99. PubMed ID: 29511925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Tc-99 measurement of glomerular filtration rate vs. calculated creatinine clearance to assess renal function pretransplant in pediatric patients undergoing hematopoietic stem cell transplantation.
    Kletzel M; Pirich L; Haut P; Cohn RA
    Pediatr Transplant; 2005 Oct; 9(5):584-8. PubMed ID: 16176414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glomerular and tubular functions in children with different forms of beta thalassemia.
    Uzun E; Balcı YI; Yüksel S; Aral YZ; Aybek H; Akdağ B
    Ren Fail; 2015; 37(9):1414-8. PubMed ID: 26365703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India.
    Choudhary D; Sharma SK; Gupta N; Kharya G; Pavecha P; Handoo A; Setia R; Katewa S
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):492-5. PubMed ID: 23160007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urine biochemical markers of early renal dysfunction are associated with iron overload in beta-thalassaemia.
    Koliakos G; Papachristou F; Koussi A; Perifanis V; Tsatra I; Souliou E; Athanasiou M
    Clin Lab Haematol; 2003 Apr; 25(2):105-9. PubMed ID: 12641614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matched Family versus Alternative Donor Hematopoietic Stem Cell Transplantation for Patients with Thalassemia Major: Experience from a Tertiary Referral Center in South India.
    Swaminathan VV; Uppuluri R; Patel S; Ravichandran N; Ramanan KM; Vaidhyanathan L; Ramakrishnan B; Jayakumar I; Raj R
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1326-1331. PubMed ID: 32200123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transplantation for thalassemia major: alternative donors.
    Locatelli F; Merli P; Strocchio L
    Curr Opin Hematol; 2016 Nov; 23(6):515-523. PubMed ID: 27537474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of bone marrow-derived mesenchymal stem cell co-transplantation with hematopoietic stem cells on liver fibrosis alleviation and survival in patients with class III β-thalassemia major.
    Rostami T; Kasaeian A; Maleki N; Nikbakht M; Kiumarsi A; Tavangar SM; Taheri APH; Mousavi SA; Ghavamzadeh A
    Stem Cell Res Ther; 2021 Mar; 12(1):213. PubMed ID: 33781314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal function in transfusion-dependent pediatric beta-thalassemia major patients.
    Jalali A; Khalilian H; Ahmadzadeh A; Sarvestani S; Rahim F; Zandian K; Asar S
    Hematology; 2011 Jul; 16(4):249-54. PubMed ID: 21756543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions.
    Galambrun C; Pondarré C; Bertrand Y; Loundou A; Bordigoni P; Frange P; Lutz P; Mialou V; Rubie H; Socié G; Schneider P; Bernaudin F; Paillard C; Michel G; Badens C; Thuret I; ;
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):62-8. PubMed ID: 22892550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-transplantation of bone marrow-derived mesenchymal stem cells with hematopoietic stem cells does not improve transplantation outcome in class III beta-thalassemia major: A prospective cohort study with long-term follow-up.
    Rostami T; Maleki N; Kasaeian A; Nikbakht M; Kiumarsi A; Asadollah Mousavi S; Ghavamzadeh A
    Pediatr Transplant; 2021 May; 25(3):e13905. PubMed ID: 33179398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thalassemia patients in transfussion dependent period and after hematopoietic stem cell transplantation: how are the psychiatric status and life quality of these patients?
    Cikili-Uytun M; Eroglu M; Ertem M; İleri DT; Ince E; Günay Kilic B
    Pediatr Hematol Oncol; 2023; 40(7):617-628. PubMed ID: 37519029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.